March 2023 - EMERG Pre-Colloquium Research Workshop - with New Members
A full EMERG meeting will take place prior to the 12th Invest in ME Research Biomedical Research into ME Colloquium at the Wellcome Genome Campus in UK in May.
New participants will join the meeting.
November 2022 - Research Paper - EMERG members publish paper on HPV
EMERG members have collaborated in HP|V research and the following paper has now been published -
Autoimmunity in patients reporting long-term complications after exposure to human papilloma virus vaccination
Several EMERG researchers were involved in this paper - including EMERG co-chair Dr Jesper Mehlsen.
October 2022 - Research Paper EMERG members publish paper from #BRMEC10
EMERG member Anders Rosén was a participant in the recently published paper -
Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic disease considered to be triggered by viral infections in a majority of cases. Symptoms overlap largely with those of post-acute sequelae of COVID-19/long-COVID implying common pathogenetic mechanisms. SARS-CoV-2 infection is risk factor for sustained latent virus reactivation that may account for the symptoms of post-viral fatigue syndromes. The aim of this study was first to investigate whether patients with ME/CFS and healthy donors (HDs) differed in their antibody response to mild/asymptomatic SARS-CoV-2 infection. Secondly, to analyze whether COVID-19 imposes latent virus reactivation in the cohorts.
October 2022 - EMERG members publish paper from #BRMEC10
In June 2021 at UK charity Invest in ME Research's tenth annual International Biomedical Research into ME Colloquium
(#BRMEC10) ME researchers from around the world met up to discuss research, both past and current,
The agenda was created with the help of The European ME Research Group
and was developed to test popular hypotheses that explain the aetiology of ME.
These included: immunogenetics and dysfunctional immune responses; an abnormal autonomous nervous system and autoimmunity; mitochondrial metabolic dysfunction; and altered host-microbe (commensal and pathogen) interactions.
A paper has been published that summarises discussions in one of the hypotheses from one of the Colloquium sessions - that immune dysfunction and viral factors may drive the development and progression of ME.
April 2022 - EMERG member wins new grant for research
EMERG member Hanna Ollila has been granted an award from the Academy of Finland for research into ME.
This was one of 22 new Academy Research Fellows selected in biosciences, health and environmental research.
The selections emphasised the high scientific quality of the projects and international research cooperation.
March 2022 - EMERG and International ME Colloquium
EMERG will again play a major role in the annual international research Colloquium organised by UK charity
Invest in ME Research. This year will be the 11th Colloquium - #BRMEC11.
EMERG will be chairing sessions in the Colloquium.
August 2021 - A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome
Researchers in Bergen suggest that ME can be linked to a failure in the energy supply to the cells.
They compared blood samples from patients with ME and a control group.
Researchers at the University of Bergen and Haukeland University Hospital, among others, have found differences in blood samples from ME patients and healthy people.
June 2021 - Therapies against endogenous retroviruses and their relationship with persistent covid, among the advances of the Gene Expression and Immunity Group
EMERG member from Spain, Professor Elisa Oltra, presented at the #BRMEC10 Colloquium recently.
The Gene Expression and Immunity research group of the Faculty of Medicine and Health Sciences of the Catholic University of Valencia (UCV),
where Elisa is the principal investigator,
recently discussed her work and that of UCV research group member Karen Giménez.
June 2021 - EMERG and International ME Colloquium
EMERG played a major part in the recent 10th Invest in ME Research International Biomedical Research into ME Colloquium #BRMEC10
that was held recently.
The main part of the agenda was formulated by EMERG in collaboration with the UK charity.
A report will be available from the Invest in ME Research web site. More information will be in the EMERG site in due course.
June 2020 - Netherlands to Fund Biomedical Research
A proposed research agenda has been submitted to the Dutch Minister of Health and includes research funding of € 20-29½ million over 10 years for a biomedical research program.Read More
January 2020 - The Prevalence of Pediatric Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in a Community-Based Sample
The prevalence of pediatric #mecfs 0.75%, a higher percentage being African American and Latinx than Caucasian. Less than 5% had been previously diagnosed with the illness. Jason, L.A., Katz, B.Z., Sunnquist, M. et al. Child Youth Care Forum (2020).Read More
June 2019 - EMECC to present at EAN Congress
Members of the The European ME Alliance (EMEA) have been working with European Federation of Neurological Associations (EFNA) to set up an awareness day for ME at the upcoming European Academy of Neurology Congress in Norway.Read More